 |
|
Wide variations in appropriateness of rectal cancer surgery across England
June 05, 2008A substantial proportion of rectal cancer patients are receiving inappropriate surgical care, because of wide variations in practice across England, reveals research published ahead of print in the journal Gut.
The variation was not associated with how far the disease had advanced or how old the patient was, the data showed.
The findings are based on information obtained from the eight cancer registries in England, which track the progress of all patients with cancer, and NHS hospital data on admissions and treatment between1998?.
During this period, 58 290 patients were diagnosed with rectal cancer in England, of whom 31 223 underwent major abdominal surgery in 153 hospitals to treat their disease.
Around 13 000 people are diagnosed with rectal cancer every year in the UK, and the disease has an annual death toll of around 5000.
There are several different surgical approaches to rectal cancer treatment, the most common of which used to be abdominoperineal excision, or APE for short.
This involves the removal of the anal sphincter, necessitating the permanent use of a colostomy bag. But mounting evidence indicates that although APE is unavoidable in some patients, it should not be the preferred procedure for most of them.
Furthermore, the evidence shows that APE is also associated with higher rates of recurrence and poorer survival than a procedure called anterior resection, or AR for short.
The Department of Health has published guidance, encouraging surgeons, wherever possible, to use alternative methods and adopt AR, which obviates the need for a colostomy bag.
The figures showed that many surgeons had taken the evidence on board, because rates of APE fell from almost one in three procedures (30.5%) in 1998 to almost one in four (23%) in 2004.
But there were wide variations in the use of APE among different cancer networks, individual surgeons as well as hospital trusts, where rates varied from 8.5% to almost 53%.
In 1998, one in three patients were also operated on a by a surgeon who performed fewer than seven rectal cancer procedures in a year. By 2004, this had fallen to around one in four (26.5%).
Patients treated by a specialist surgeon undertaking seven or more cases of rectal cancer a year were 23% less likely to be treated with APE than those with less experience.
The figures also revealed that those living in the most deprived areas of the country were significantly more likely to receive an APE than those living in the most affluent areas.
There were no obvious clinical reasons for these discrepancies, the findings showed.
APE may not only spell poorer quality of life for patients, but it is also more expensive, in terms of the maintenance costs of colostomies and the treatment of recurrent disease, say the authors.
"These problems must be addressed if the government is to attain its aims of ensuring a high quality of cancer care for all," they conclude.
BMJ-British Medical Journal
During this period, 58 290 patients were diagnosed with rectal cancer in England, of whom 31 223 underwent major abdominal surgery in 153 hospitals to treat their disease.
Around 13 000 people are diagnosed with rectal cancer every year in the UK, and the disease has an annual death toll of around 5000.
There are several different surgical approaches to rectal cancer treatment, the most common of which used to be abdominoperineal excision, or APE for short.
This involves the removal of the anal sphincter, necessitating the permanent use of a colostomy bag. But mounting evidence indicates that although APE is unavoidable in some patients, it should not be the preferred procedure for most of them.
Furthermore, the evidence shows that APE is also associated with higher rates of recurrence and poorer survival than a procedure called anterior resection, or AR for short.
The Department of Health has published guidance, encouraging surgeons, wherever possible, to use alternative methods and adopt AR, which obviates the need for a colostomy bag.
The figures showed that many surgeons had taken the evidence on board, because rates of APE fell from almost one in three procedures (30.5%) in 1998 to almost one in four (23%) in 2004.
But there were wide variations in the use of APE among different cancer networks, individual surgeons as well as hospital trusts, where rates varied from 8.5% to almost 53%.
In 1998, one in three patients were also operated on a by a surgeon who performed fewer than seven rectal cancer procedures in a year. By 2004, this had fallen to around one in four (26.5%).
Patients treated by a specialist surgeon undertaking seven or more cases of rectal cancer a year were 23% less likely to be treated with APE than those with less experience.
The figures also revealed that those living in the most deprived areas of the country were significantly more likely to receive an APE than those living in the most affluent areas.
There were no obvious clinical reasons for these discrepancies, the findings showed.
APE may not only spell poorer quality of life for patients, but it is also more expensive, in terms of the maintenance costs of colostomies and the treatment of recurrent disease, say the authors.
"These problems must be addressed if the government is to attain its aims of ensuring a high quality of cancer care for all," they conclude.
BMJ-British Medical Journal
Rectal Cancer Current Events and Rectal Cancer News RSSMinimally Invasive Surgery Shown Safe and Effective Treatment for Rectal Cancer
Laparoscopic surgery has been used in the treatment of intestinal disorders for close to 20 years, but its benefits have only recently begun to be extended to people with rectal cancer.
Cancer drug is no different in effectiveness as gold standard treatment for macular degeneration
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Colorectal cancer
Previously, only a few genes had been associated with the formation of metastases in colorectal cancer. Now, researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité - University Medicine Berlin, Germany, have identified 115 genes that are disregulated both in the primary tumor and in its metastases.
What are the risk factors of sporadic colorectal cancer?
Colorectal cancer (CRC) is one of the most common cancers in China.
A surprise 'spark' for pre-cancerous colon polyps
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah studied the events leading to colon cancer and found that an unexpected protein serves as the "spark" that triggers formation of colon polyps, the precursors to cancerous tumors.
Cancer-obesity link discovery by MSU researchers could aid prevention efforts
A new link between body fat and cancer identified by a Michigan State University researcher underscores obesity's health risk and could lead to new cancer treatment and prevention strategies.
Pitt vaccine to prevent colon cancer being tested in patients
Researchers at the University of Pittsburgh School of Medicine have begun testing a vaccine that might be able to prevent colon cancer in people at high risk for developing the disease.
How to increase the efficacy of local excision of rectal cancer
With the advancement of imaging techniques, the accuracy of preoperative rectal cancer staging has increased dramatically, and the preservation of physical function in rectal cancer patients has become a very important aim of research.
No differences in survival or neonatal outcomes in pregnancy-associated colorectal cancer
In one of the first studies to examine maternal and newborn health risks and colorectal cancer, UC Davis researchers have found that women diagnosed with the disease during or shortly after their pregnancies have the same survival as women who have the disease and are not pregnant.
People who exercise lower their risk of colon cancer
An ambitious new study has added considerable weight to the claim that exercise can lower the risk for colon cancer. Researchers at Washington University School of Medicine in St. Louis and Harvard University combined and analyzed several decades worth of data from past studies on how exercise affects colon cancer risk.
More Rectal Cancer Current Events and Rectal Cancer News Articles
 |
Positive Options for Colorectal Cancer: Self-Help and Treatment by Carol Ann Larson (Author), Kathleen Ogle (Foreword) Colorectal cancer develops slowly over a period of several years, undetected, usually as polyps. It is a preventable and treatable disease if caught in time, yet most know little about how to read its symptoms. Written for the layperson, this book covers all the uncomfortable questions and answers about the disease, from prevention and warning signs, to screening and diagnosis techniques, to making decisions and developing treatment plans. Also included are positive stories about life after cancer by 12 survivors. |
 |
Rectal Cancer: New Frontiers in Diagnosis, Treatment and Rehabilitation by Gian Gaetano Delaini (Editor) Despite lifestyle improvements, the incidence of rectal cancer is increasing in industrialised countries. Rapid advances in technology, growing knowledge of the biological history of the disease and closer attention to patients' quality of life after surgery have led to a less invasive approach. In the last 15 years, the surgical approach has shifted from extended resection to sphincter-saving procedures, featuring a multidiscipinary approach and a high level of specialisation. The experienced surgeon can plan and choose the "right treatment for the right patient" only with the support of the radiologist, endoscopist and pathologist (preoperative staging), oncologist and radiotherapist (neoadjuvant therapy), and psychologist and stomatherapist (rehabilitation). In addition, the difficult... |
|
Colon and Rectal Cancer at Time of Diagnosis Includes workbook. | |
 |
Rectal Cancer Awareness Ribbon Mouse Pad by MyHeritageWear.com The Rectal Cancer Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Rectal Cancer Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Rectal Cancer Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Beating Rectal Cancer Together Sweatshirt Small White by Shop Zeus |
 |
Cure Rectal Cancer Keychain by Design a Product LLC Text on keychain: Cure Rectal Cancer * Durable acrylic key chain is crystal-clear and double-sided so the artwork or message is seen twice. * Sturdy metal ring holds your keys securely. * Full color printed images or messages are included. * If you have new ideas or need help selecting text for your custom keychains please contact us. * Size: 2 1/8" x 3 1/2" (Approx. business card) |
 |
New Tests, Treatments: Better Outcome for Colorectal Cancer Colorectal cancer is the third most common cancer and the second leading cause of cancer mortality in the U.S. Advances in imaging, genetics, molecular diagnostics, surgical techniques and chemotherapy are now making significant gains in our ability to prevent, diagnose, and treat this serious disease. Dr. Fisher reviews some of these recent successes and shares a vision of future care based on current research. |
 |
EZ DETECT Home Test for Early Warning Signs of Colorectal Disease - 1 ea by EZ DETECT One Kit Contains Five Test Pads. Self Check for Intestinal Bleeding Even Be |
|
EarlyDetect Colon Screening, 1-Count Box (Pack of 2) by EarlyDETECT | |
 |
The Intelligent Patient Guide to Colorectal Cancer: Information, risk, prevention, symptoms, signs, diagnosis, stage, surgery, radiation, chemotherapy, prognosis, treatment of/for colon rectal cancer. by Michael E. Pezim (Author), David A. Owen (Author) The Intelligent Patient Guide book series was created in 1989 by a group of American and Canadian-trained physicians frustrated by the lack of quality information available for their cancer patients. The books became bestsellers, and their appeal has grown despite the development of the Internet. Whereas the Internet is an explosion of medical information that can confuse and intimidate, these books are personal guides designed to equip the patient to take an active role in their care by providing clear, organized and relevant information that gives them back a sense of control. In cancer centers across the country it is not uncommon to see a well-worn, personal copy of an Intelligent Patient Guide under the under the arm or at the bedside of a patient awaiting treatment. The books... |
| © 2009 BrightSurf.com |